FTC Fought Long, Hard Battle Against Pay-For-Delay Deals

When the U.S. Supreme Court ruled Monday that so-called pay-for-delay settlements between branded drugmakers and generic rivals could face antitrust scrutiny, it represented a huge win for the Federal Trade Commission...

Already a subscriber? Click here to view full article